Nukkleus Inc. Announces Strategic $10.0 Million Private Placement Priced At-the-Market
Nukkleus (NASDAQ: NUKK), an Aerospace and Defense strategic acquirer, has announced a $10.0 million private placement priced at-the-market. The placement includes a $9.5 million investment from Esousa Group Holdings and $500,000 from Sixth Borough Capital Fund.
The company will issue 200 units at $50,000 per unit, each consisting of Series A convertible preferred stock and warrants to purchase 15,957 common shares. The preferred stock is convertible at $4.89 per share, while warrants are exercisable at $5.405 per share.
Proceeds will fund strategic acquisitions including Tiltan Software Engineering (AI defense software), 51% of Star 26 Capital (Iron Dome components), and establishment of manufacturing zones in the Baltics and Israel through a joint venture with Mandragola Ltd. The placement is expected to close around September 9, 2025.
Nukkleus (NASDAQ: NUKK), acquirente strategico nei settori Aerospace e Defense, ha annunciato un collocamento privato da 10,0 milioni di dollari a prezzo di mercato. Il collocamento include un investimento di 9,5 milioni di dollari da Esousa Group Holdings e 500.000 dollari da Sixth Borough Capital Fund.
La società emetterà 200 unità a 50.000 dollari ciascuna, ognuna costituita da azioni privilegiate convertibili Serie A e warrant per l'acquisto di 15.957 azioni ordinarie. Le azioni privilegiate sono convertibili a 4,89 dollari per azione, mentre i warrant sono esercitabili a 5,405 dollari per azione.
I proventi finanzieranno acquisizioni strategiche tra cui Tiltan Software Engineering (software di difesa basato su AI), l'acquisto del 51% di Star 26 Capital (componenti per Iron Dome) e la creazione di zone produttive nei Paesi baltici e in Israele tramite una joint venture con Mandragola Ltd. La chiusura del collocamento è prevista intorno al 9 settembre 2025.
Nukkleus (NASDAQ: NUKK), un adquirente estratégico en los sectores Aeroespacial y de Defensa, ha anunciado una colocación privada por 10,0 millones de dólares a precio de mercado. La operación incluye una inversión de 9,5 millones de dólares de Esousa Group Holdings y 500.000 dólares de Sixth Borough Capital Fund.
La compañía emitirá 200 unidades a 50.000 dólares cada una, cada una compuesta por acciones preferentes convertibles Serie A y warrants para comprar 15.957 acciones ordinarias. Las preferentes son convertibles a 4,89 dólares por acción, mientras que los warrants son ejercitables a 5,405 dólares por acción.
Los fondos financiarán adquisiciones estratégicas como Tiltan Software Engineering (software de defensa con IA), la compra del 51% de Star 26 Capital (componentes del Iron Dome) y el establecimiento de zonas de producción en los países bálticos e Israel mediante una joint venture con Mandragola Ltd. Se espera que el cierre de la colocación ocurra alrededor del 9 de septiembre de 2025.
Nukkleus (NASDAQ: NUKK), 항공우주·국방 분야 전략적 인수 기업이 시장가 기준 1,000만 달러 규모의 사모 발행을 발표했습니다. 이번 발행에는 Esousa Group Holdings의 950만 달러 투자와 Sixth Borough Capital Fund의 50만 달러가 포함됩니다.
회사는 단가 50,000달러의 200 유닛을 발행하며, 각 유닛은 시리즈 A 전환우선주와 15,957주를 매수할 수 있는 워런트를 포함합니다. 전환우선주는
자금은 AI 기반 방위 소프트웨어인 Tiltan Software Engineering, Iron Dome 부품 관련 Star 26 Capital의 51% 인수, 그리고 Mandragola Ltd와의 합작투자를 통해 발틱 지역 및 이스라엘에 제조 거점 설립 등 전략적 인수에 사용될 예정입니다. 거래 종결은 2025년 9월 9일경으로 예상됩니다.
Nukkleus (NASDAQ: NUKK), acquéreur stratégique dans les secteurs aérospatial et défense, a annoncé un placement privé de 10,0 millions de dollars au prix du marché. Le placement comprend un investissement de 9,5 millions de dollars de la part d'Esousa Group Holdings et 500 000 dollars de Sixth Borough Capital Fund.
La société émettra 200 unités à 50 000 dollars chacune, chaque unité comprenant des actions privilégiées convertibles de série A et des bons de souscription permettant d'acheter 15 957 actions ordinaires. Les actions privilégiées sont convertibles à 4,89 dollars par action, tandis que les warrants sont exerçables à 5,405 dollars par action.
Les fonds serviront à financer des acquisitions stratégiques, notamment Tiltan Software Engineering (logiciel de défense à base d'IA), l'acquisition de 51 % de Star 26 Capital (composants pour Iron Dome) et la création de zones de production dans les pays baltes et en Israël via une coentreprise avec Mandragola Ltd. La clôture du placement est prévue aux alentours du 9 septembre 2025.
Nukkleus (NASDAQ: NUKK), ein strategischer Akquisiteur im Bereich Luft- und Raumfahrt sowie Verteidigung, hat eine Private Placement über 10,0 Millionen US-Dollar zum Marktpreis angekündigt. Das Placement umfasst eine 9,5-Millionen-US-Dollar-Investition von Esousa Group Holdings sowie 500.000 US-Dollar von Sixth Borough Capital Fund.
Das Unternehmen wird 200 Einheiten zu je 50.000 US-Dollar ausgeben, wobei jede Einheit aus wandelbaren Vorzugsaktien der Serie A und Warrants zum Erwerb von 15.957 Stammaktien besteht. Die Vorzugsaktien sind zu 4,89 US-Dollar je Aktie wandelbar, die Warrants sind zu 5,405 US-Dollar je Aktie ausübbar.
Die Erlöse sollen strategische Akquisitionen finanzieren, darunter Tiltan Software Engineering (KI-gestützte Verteidigungssoftware), der Erwerb von 51 % an Star 26 Capital (Komponenten für das Iron Dome) sowie die Einrichtung von Fertigungsstandorten in den baltischen Staaten und Israel in einem Joint Venture mit Mandragola Ltd. Der Abschluss des Placements wird voraussichtlich um den 9. September 2025 erfolgen.
- Significant $10.0 million capital injection to fund strategic acquisitions
- Expansion into AI defense software through Tiltan acquisition
- Strategic entry into Iron Dome defense system through Star 26 Capital acquisition
- Geographic expansion with new manufacturing facilities in Baltics and Israel
- Backing from established investors including Esousa Group Holdings
- Potential dilution for existing shareholders through preferred stock conversion
- Additional dilution risk from warrant exercises
- Complex security structure with anti-dilution provisions
- Securities offered at a discount to market price
Insights
Nukkleus secures $10M strategic funding to acquire defense companies and expand operations in a carefully structured financing deal.
Nukkleus Inc. (NASDAQ: NUKK) has secured a
The financing terms reveal a conversion price of
The capital infusion is strategically earmarked for four distinct growth initiatives: (1) acquiring Tiltan Software Engineering, an AI defense software provider; (2) obtaining a
This transaction represents a significant pivot toward the aerospace and defense sector, moving beyond Nukkleus's traditional business focus. The company has engaged Dawson James Securities as the exclusive placement agent and has committed to filing registration statements with the SEC to provide liquidity for the investors' securities. The structure includes anti-dilution protections for investors while giving Nukkleus call rights on the warrants, providing some flexibility for the company if its stock price appreciates substantially.
Net proceeds to fund pending acquisitions and business expansion initiatives
NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Nukkleus, Inc. (NASDAQ: NUKK), a strategic acquirer and developer of high-potential businesses in the Aerospace and Defense related (A&D) industries, today announced the pricing of a private placement led with a
The Company intends to use the net proceeds from the private placement to fund its previously announced, pending strategic acquisitions and business expansion initiatives, including:
- Acquisition of Tiltan Software Engineering Ltd., an AI software provider for the defense market.
- Acquisition of
51% of Star 26 Capital, a defense company which holds100% ownership in RIMON, a leading Israeli supplier of components for the Iron Dome missile defense system, as well as other defense and tactical solutions. - Establishment of advanced manufacturing zones in both the Baltics and Israel, designed to support civil and defense aviation needs, via a joint venture with Mandragola Ltd., a leading Israeli business development and investment company specialized in advanced technologies and strategic partnerships. which will mark Nukkleus’ entrance into commercial aviation services.
- Commercialization of drone payload license from Blade Ranger Ltd. (TASE: BLRN), an innovator of advanced drone payload systems for defense, homeland security, and solar applications, which will mark Nukkleus’ entrance into commercial aviation services.
In connection with the private placement, the Company has agreed to issue an aggregate of 200 units. Each unit will be sold at a price per unit of
Each common warrant represents the right to purchase one share of unregistered common stock, and is exercisable at an exercise price of
The closing of the private placement is expected to occur on or about September 9, 2025, subject to the satisfaction of certain customary closing conditions.
For a more fulsome description of the private placement transaction, including the securities issued in the transaction, please review our Current Report on Form 8-K filed with the Securities and Exchange Commission on September 5, 2025.
Dawson James Securities is acting as the Exclusive Placement Agent for the private placement.
The Series A convertible preferred stock and common warrants (and the shares of common stock and/or pre-funded warrants issuable upon conversion of the Series A convertible preferred stock and upon exercise of the common warrants) described above are being offered in a private placement exempt from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Act”), and have not been registered under the Act, or applicable state securities laws. Accordingly, the securities may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Act and such applicable state securities laws. Pursuant to a registration rights agreement with the investors, the Company has agreed to file one or more registration statements with the Securities and Exchange Commission (the “SEC”) registering the resale of the shares of common stock issuable upon conversion of the Series A convertible preferred stock and the shares of common stock issuable upon exercise of the common warrants sold in the private placement and shares of common stock issuable upon the exercise of pre-funded warrants, if any, issued upon conversion of the Series A convertible preferred stock.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.
About Nukkleus Inc.
Nukkleus Inc. (NASDAQ: NUKK) focuses on acquiring and scaling mission-critical suppliers across the defense, aerospace, and advanced manufacturing sectors. With planned operations in the United States and Israel, Nukkleus is targeting Tier 2 and Tier 3 companies that form the industrial backbone of national security infrastructure. Through its planned proprietary capital model, Nukkleus expects to integrate operational capabilities, financial discipline, and long-term vision to modernize and expand strategic suppliers—supporting dual-use innovation and resilient supply chains.
The company’s portfolio approach is expected to combine organic growth with disciplined M&A, potentially enabling transformational scale and positioning Nukkleus at the core of 21st-century defense industrial strategy.
Forward-Looking Statements
This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts, including, but not limited to, statements related to the closing of the private placement and the ability for the Company to utilize the financing to fund acquisitions and business expansion and statements regarding the pending acquisitions of Tiltan Software Engineering Ltd. and Star26 Capital, the joint venture with Mandragola Ltd., the planned commercialization of drone payload license from Blade Ranger Ltd are "forward-looking statements" within the meaning of federal securities laws. In some cases, you can identify forward-looking statements by terminology such as "will," "would," "expect," "intend," "plan," "objective," or comparable terminology referencing future events, conditions or circumstances, or the negative of such terms. Although Nukkleus believes that it has a reasonable basis for the forward-looking statements contained in this press release, they are based on management's current beliefs and expectations about future events and circumstances and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond the Company's control. Risk factors including, but not limited to, the risk that the closing of the offering may not occur as expected or at all and the anticipated use of proceeds, uncertainty regarding the satisfaction or waiver of all closing conditions to complete the acquisitions of Tiltan Software Engineering Ltd. and Star26 Capital, the risk that the acquisitions may not be completed on the terms or in the time frame expected by the company, unexpected costs, charges or expenses resulting from the acquisitions, the company’s ability to successfully implement the joint venture with Mandragola Ltd., the market adoption of the planned commercialization of drone payload license from Blade Ranger Ltd, the ability of the company to implement its business strategy, uncertainty regarding third-party market projections, market volatility, competition, litigation, and those other risks described under "Risk Factors" in Nukkleus' most recently filed annual report on Form 10-K, as updated from time to time in its quarterly reports on Form 10-Q and other filings with the Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by forward-looking statements in this press release. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Nukkleus undertakes no obligation to update any forward-looking statement contained in this press release to reflect events that occur or circumstances that exist after the date of this press release, except as required by law.
For more information, please contact:
Investor Relations Contacts (US):
The Equity Group Inc.
Lena Cati
lcati@theequitygroup.com
+1 (212) 836-9611
Val Ferraro
vferraro@theequitygroup.com
+1 (212) 836-9633
FAQ
What is the size and structure of Nukkleus (NUKK) private placement announced in September 2025?
How will Nukkleus (NUKK) use the proceeds from the $10M private placement?
What is the conversion price for NUKK's Series A preferred stock and warrant exercise price?
Who are the main investors in Nukkleus's September 2025 private placement?
When is the expected closing date for NUKK's private placement?
